Single‐dose oral challenges to validate eliciting doses in children with cow’s milk allergy
Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (...
Saved in:
Published in | Pediatric allergy and immunology Vol. 32; no. 5; pp. 1056 - 1065 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.07.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0905-6157 1399-3038 1399-3038 |
DOI | 10.1111/pai.13482 |
Cover
Abstract | Background
There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.
Methods
Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.
Results
172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein.
Conclusions
These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed. |
---|---|
AbstractList | There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.BACKGROUNDThere is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.METHODSParticipants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein.RESULTS172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein.These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.CONCLUSIONSThese data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed. Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein. Methods Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity. Results 172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein. Conclusions These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed. There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED for cow's milk of 0.5 mg protein. Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity. 172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein. These data support an estimated ED for cow's milk of 0.5 mg protein. Values for ED above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed. BackgroundThere is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk‐allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single‐dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein.MethodsParticipants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity.Results172 children (median age 6.0 (IQR 0.7‐11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%‐11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single‐dose challenge using 0.5 mg cow's milk protein.ConclusionsThese data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed. |
Author | Baumert, Joseph L. Turner, Paul J. Marco‐Martin, Guadalupe Bazire, Raphaëlle Mills, Clare E. N. Ebisawa, Motohiro Duca, Bettina van Ree, Ronald Fernandez‐Rivas, Montserrat Vera‐Berrios, Rosialzira N. Vazquez‐Ortiz, Marta Hourihane, Jonathan O'B. Alvarez, Olaya Chastell, Sophia A. Rodríguez del Río, Pablo d'Art, Yvonne M. |
Author_xml | – sequence: 1 givenname: Paul J. orcidid: 0000-0001-9862-5161 surname: Turner fullname: Turner, Paul J. email: p.turner@imperial.ac.uk organization: Imperial College London – sequence: 2 givenname: Yvonne M. surname: d'Art fullname: d'Art, Yvonne M. organization: University College Cork – sequence: 3 givenname: Bettina surname: Duca fullname: Duca, Bettina organization: Imperial College London – sequence: 4 givenname: Sophia A. surname: Chastell fullname: Chastell, Sophia A. organization: Imperial College London – sequence: 5 givenname: Guadalupe surname: Marco‐Martin fullname: Marco‐Martin, Guadalupe organization: ARADyAL Research Network – sequence: 6 givenname: Rosialzira N. surname: Vera‐Berrios fullname: Vera‐Berrios, Rosialzira N. organization: ARADyAL Research Network – sequence: 7 givenname: Olaya surname: Alvarez fullname: Alvarez, Olaya organization: Health Research Institute Princesa – sequence: 8 givenname: Raphaëlle orcidid: 0000-0003-0079-3613 surname: Bazire fullname: Bazire, Raphaëlle organization: Health Research Institute Princesa – sequence: 9 givenname: Pablo surname: Rodríguez del Río fullname: Rodríguez del Río, Pablo organization: Health Research Institute Princesa – sequence: 10 givenname: Marta orcidid: 0000-0001-5493-6056 surname: Vazquez‐Ortiz fullname: Vazquez‐Ortiz, Marta organization: Imperial College London – sequence: 11 givenname: Joseph L. surname: Baumert fullname: Baumert, Joseph L. organization: University of Nebraska – sequence: 12 givenname: Ronald surname: van Ree fullname: van Ree, Ronald organization: Amsterdam University Medical Centres – sequence: 13 givenname: Clare E. N. surname: Mills fullname: Mills, Clare E. N. organization: University of Manchester – sequence: 14 givenname: Montserrat surname: Fernandez‐Rivas fullname: Fernandez‐Rivas, Montserrat organization: ARADyAL Research Network – sequence: 15 givenname: Jonathan O'B. orcidid: 0000-0003-4997-9857 surname: Hourihane fullname: Hourihane, Jonathan O'B. organization: Children's Health Ireland – sequence: 16 givenname: Motohiro surname: Ebisawa fullname: Ebisawa, Motohiro |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33608940$$D View this record in MEDLINE/PubMed |
BookMark | eNp90c1KxDAQB_Agiq4fB19AAl70UE2apk2OIn6BoKCeQ9pO12g2WZOuy958BK--nk9i1lUPguYSAr8ZJvNfR8vOO0Bom5IDms7hWJsDygqRL6EBZVJmjDCxjAZEEp6VlFdraD3GB0JoxUq6itYYK4mQBRkgdWPc0ML7y2vrI2AftMXNvbYW3BAi7j1-1ta0ugcM1jSmTxzPacTGJWlsG8DhqenvceOn7y9vEY-MfcTzFmE420QrnbYRtr7uDXR3enJ7fJ5dXp1dHB9dZg0TIs94I_KiFDXoSrCSiapkROeC8062rK5FmZei43mXfpueUra1gKprq6KFgsqGsA20t-g7Dv5pArFXIxMbsFY78JOo8kJSWXApi0R3f9EHPwkuTadynoYgrOI8qZ0vNalH0KpxMCMdZup7dQnsL0ATfIwBuh9CiZrHolIs6jOWZA9_2bRJ3Rvv-qCN_a9iaizM_m6tro8uFhUfPhOehg |
CitedBy_id | crossref_primary_10_1016_j_jaip_2021_05_021 crossref_primary_10_1111_all_16012 crossref_primary_10_1016_j_fct_2022_113381 crossref_primary_10_1016_j_jaip_2021_08_008 crossref_primary_10_1111_all_15397 crossref_primary_10_46563_1560_9561_2023_26_5_368_375 crossref_primary_10_1111_all_15863 crossref_primary_10_1111_all_15202 crossref_primary_10_1111_pai_13926 crossref_primary_10_1097_ACI_0000000000000906 crossref_primary_10_1097_ACI_0000000000000979 crossref_primary_10_1111_all_15749 crossref_primary_10_1016_j_jaip_2022_12_042 crossref_primary_10_1016_j_waojou_2024_100972 crossref_primary_10_1007_s11882_024_01129_x crossref_primary_10_1016_j_jaci_2022_04_035 crossref_primary_10_1016_j_jaip_2022_10_044 crossref_primary_10_1016_j_waojou_2024_101012 crossref_primary_10_3390_nu15061397 crossref_primary_10_1016_j_anai_2023_12_012 crossref_primary_10_1159_000541840 crossref_primary_10_1016_j_jaci_2024_03_019 crossref_primary_10_1111_1541_4337_70132 |
Cites_doi | 10.1016/j.jaci.2017.01.030 10.1111/j.1398-9995.2012.02865.x 10.1046/j.1365-2222.2000.00928.x 10.1016/j.alit.2017.02.001 10.1111/j.1399-3038.2010.00990.x 10.1111/all.12614 10.1016/j.jaci.2005.12.1303 10.1111/all.13198 10.1016/j.jaci.2013.06.042 10.1111/pai.12148 10.1111/all.12613 10.1016/j.jaip.2020.06.059 10.1186/s12889-018-6117-y 10.1016/j.jaci.2014.03.035 10.1016/j.jaci.2012.10.017 10.3389/fimmu.2018.02057 10.1016/j.fct.2013.10.032 10.1016/j.fct.2020.111831 10.1111/j.1398-9995.2011.02715.x 10.1016/j.fct.2020.111259 10.1067/mai.2001.114708 10.1016/j.jaci.2019.07.046 10.1016/j.jaip.2019.04.025 10.1186/s40413-016-0104-5 10.1136/bmj.d6180 10.1111/pai.13244 10.1111/all.12625 |
ContentType | Journal Article |
Copyright | 2021 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. 2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. – notice: 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. – notice: 2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1111/pai.13482 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3038 |
EndPage | 1065 |
ExternalDocumentID | 33608940 10_1111_pai_13482 PAI13482 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Jon Moulton Charity Trust – fundername: Medical Research Council – fundername: Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica – fundername: Fundación de la Sociedad Española de Alergología e Inmunología Clínica – fundername: FP7 Food, Agriculture and Fisheries, Biotechnology – fundername: NIHR Imperial Biomedical Research Centre – fundername: ARADyAL – fundername: Medical Research Council grantid: MR/S036954/1 – fundername: Department of Health – fundername: Medical Research Council grantid: MR/K010468/1 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J8S K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 ESTFP H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c3882-5c82468bea7836387630a2855f9d3bb86268f52f1113bb99db8e7fd74de419c03 |
IEDL.DBID | DR2 |
ISSN | 0905-6157 1399-3038 |
IngestDate | Fri Sep 05 12:02:25 EDT 2025 Sun Sep 07 00:40:35 EDT 2025 Mon Jul 21 05:35:44 EDT 2025 Tue Jul 01 01:25:26 EDT 2025 Thu Apr 24 22:57:35 EDT 2025 Wed Jan 22 16:28:34 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | cow's milk eliciting dose thresholds Voluntary Incidental Trace Allergen Labelling (VITAL) single-dose challenge |
Language | English |
License | Attribution 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3882-5c82468bea7836387630a2855f9d3bb86268f52f1113bb99db8e7fd74de419c03 |
Notes | Funding information Clinical challenges in the SOCMA study were funded through grant funds awarded by Jon Moulton Charity Trust, UK Medical Research Council (ref MR/S036954/1), Sociedad Española de Alergología e Inmunología Clínica (SEAIC), Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica (SEICAP) and Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0026). iFAAM (Integrated Approaches to Food Allergen and Allergy Risk Management) challenges were funded through the European Union's Seventh Framework Program for research, technological development and demonstration (grant agreement no. 312147). Additional funding for the Irish centre was obtained via a research fellowship (YD) from the National Children's Research Centre of Ireland, and for Hospital Clinico San Carlos in Madrid by Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0009). PJT is supported through the NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR, or the Department of Health. The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-0079-3613 0000-0003-4997-9857 0000-0001-9862-5161 0000-0001-5493-6056 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.13482 |
PMID | 33608940 |
PQID | 2546803755 |
PQPubID | 105695 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2491945994 proquest_journals_2546803755 pubmed_primary_33608940 crossref_primary_10_1111_pai_13482 crossref_citationtrail_10_1111_pai_13482 wiley_primary_10_1111_pai_13482_PAI13482 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2021 2021-07-00 20210701 |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: July 2021 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Montpellier |
PublicationTitle | Pediatric allergy and immunology |
PublicationTitleAlternate | Pediatr Allergy Immunol |
PublicationYear | 2021 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2019; 7 2015; 70 2013; 24 2017; 66 2020; 146 2014; 63 2012; 14 2014; 133 2001; 107 2018; 21 2006; 117 2019; 144 2017; 139 2014; 134 2016; 11 2020; 8 2017; 72 2012; 130 2018; 18 2020; 31 2020 2000; 30 2020; 139 2011; 22 2012; 67 2011; 343 e_1_2_12_4_1 e_1_2_12_3_1 e_1_2_12_6_1 e_1_2_12_5_1 e_1_2_12_19_1 e_1_2_12_18_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_16_1 Baseggio Conrado A (e_1_2_12_12_1) 2020 e_1_2_12_20_1 e_1_2_12_21_1 e_1_2_12_22_1 e_1_2_12_23_1 e_1_2_12_24_1 e_1_2_12_25_1 e_1_2_12_26_1 e_1_2_12_27_1 e_1_2_12_28_1 e_1_2_12_29_1 e_1_2_12_30_1 e_1_2_12_31_1 Levy MB (e_1_2_12_15_1) 2012; 14 e_1_2_12_14_1 e_1_2_12_13_1 e_1_2_12_8_1 e_1_2_12_11_1 e_1_2_12_7_1 e_1_2_12_10_1 e_1_2_12_9_1 |
References_xml | – volume: 8 start-page: 3660 issue: 10 year: 2020 end-page: 3662 article-title: Effect of specific IgE on eliciting dose in children with cow's milk allergy publication-title: J Allergy Clin Immunol Pract – volume: 66 start-page: 248 issue: 2 year: 2017 end-page: 264 article-title: Committee for Japanese pediatric guideline for food allergy, the Japanese Society of Pediatric Allergy and Clinical Immunology, The Japanese Society of Allergology. Japanese guidelines for food allergy 2017 publication-title: Allergol Int – volume: 67 start-page: 107 issue: 1 year: 2012 end-page: 113 article-title: Development of a standardized low‐dose double‐blind placebo‐controlled challenge vehicle for the EuroPrevall project publication-title: Allergy – volume: 70 start-page: 1039 issue: 9 year: 2015 end-page: 1051 article-title: Precautionary allergen labelling: perspectives from key stakeholder groups publication-title: Allergy – volume: 7 start-page: 2241 issue: 7 year: 2019 end-page: 2249 article-title: Epidemiology of anaphylaxis in critically Ill children in the United States and Canada publication-title: J Allergy Clin Immunol Pract – volume: 139 year: 2020 article-title: Updated population minimal eliciting dose distributions for use in risk assessment of 14 priority food allergens publication-title: Food Chem Toxicol – volume: 30 start-page: 1540 issue: 11 year: 2000 end-page: 1546 article-title: Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children publication-title: Clin Exp Allergy – volume: 18 start-page: 1263 issue: 1 year: 2018 article-title: Comparing the eating out experiences of consumers seeking to avoid different food allergens publication-title: BMC Public Health – volume: 70 start-page: 880 issue: 7 year: 2015 end-page: 883 article-title: Increased incidence of admissions for anaphylaxis in Spain 1998–2011 publication-title: Allergy – volume: 24 start-page: 624 issue: 7 year: 2013 end-page: 626 article-title: Persistent allergy to cow's milk: of greater a clinical concern than other food allergies publication-title: Pediatr Allergy Immunol – volume: 146 year: 2020 article-title: Full range of population eliciting dose values for 14 priority allergenic foods and recommendations for use in risk characterization publication-title: Food Chem Toxicol – volume: 31 start-page: 601 issue: 6 year: 2020 end-page: 607 article-title: Can my child with IgE‐mediated peanut allergy introduce foods labeled with "may contain traces"? publication-title: Pediatr Allergy Immunol – volume: 70 start-page: 813 issue: 7 year: 2015 end-page: 819 article-title: Unintended allergens in precautionary labelled and unlabelled products pose significant risks to UK allergic consumers publication-title: Allergy – volume: 133 start-page: 156 issue: 1 year: 2014 end-page: 164 article-title: Allergen reference doses for precautionary labeling (VITAL 2.0): clinical implications publication-title: J Allergy Clin Immunol – volume: 134 start-page: 390 issue: 2 year: 2014 end-page: 398 article-title: Modified oral food challenge used with sensitisation biomarkers provides more real‐life clinical thresholds for peanut allergy publication-title: J Allergy Clin Immunol – volume: 21 start-page: 2057 issue: 9 year: 2018 article-title: Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges publication-title: Front Immunol – volume: 107 start-page: 891 issue: 5 year: 2001 end-page: 896 article-title: Utility of food‐specific IgE concentrations in predicting symptomatic food allergy publication-title: J Allergy Clin Immunol – volume: 63 start-page: 9 year: 2014 end-page: 17 article-title: Establishment of reference doses for residues of allergenic foods: report of the VITAL Expert Panel publication-title: Food Chem Toxicol – volume: 130 start-page: 1260 issue: 6 year: 2012 end-page: 1274 article-title: Standardizing double‐blind, placebo‐controlled oral food challenges: American Academy of Allergy, Asthma & Immunology‐European Academy of Allergy and Clinical Immunology PRACTALL consensus report publication-title: J Allergy Clin Immunol – volume: 343 start-page: d6180 year: 2011 article-title: Advisory food labels: consumers with allergies need more than "traces" of information publication-title: BMJ – volume: 144 start-page: 1290 issue: 5 year: 2019 end-page: 1309 article-title: Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens publication-title: J Allergy Clin Immunol – volume: 139 start-page: 1583 issue: 5 year: 2017 end-page: 1590 article-title: Peanut Allergen Threshold Study (PATS): novel single‐dose oral food challenge study to validate eliciting doses in children with peanut allergy publication-title: J Allergy Clin Immunol – volume: 22 start-page: 172 issue: 2 year: 2011 end-page: 177 article-title: Anaphylaxis in Israel: experience with 92 hospitalized children publication-title: Pediatr Allergy Immunol – volume: 72 start-page: 1816 issue: 11 year: 2017 end-page: 1819 article-title: Minimal impact of extensive heating of hen's egg and cow's milk in a food matrix on threshold dose‐distribution curves publication-title: Allergy – volume: 14 start-page: 29 issue: 1 year: 2012 end-page: 33 article-title: Lessons from 482 cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen publication-title: Isr Med Assoc J – year: 2020 article-title: Food Anaphylaxis in the United Kingdom: an analysis of national data. 1998–2018 publication-title: BMJ – volume: 67 start-page: 976 year: 2012 end-page: 997 article-title: International consensus on (ICON) pediatric asthma publication-title: Allergy – volume: 11 start-page: 12 issue: 9 year: 2016 article-title: Allergic reactions to milk appear sooner than reactions to hen's eggs: a retrospective study publication-title: World Allergy Organ J – volume: 117 start-page: 391 year: 2006 end-page: 397 article-title: Second symposium on the definition and management of anaphylaxis: summary report—second national institute of allergy and infectious disease/food allergy and anaphylaxis network symposium publication-title: J Allergy Clin Immunol – ident: e_1_2_12_4_1 doi: 10.1016/j.jaci.2017.01.030 – ident: e_1_2_12_19_1 doi: 10.1111/j.1398-9995.2012.02865.x – ident: e_1_2_12_30_1 doi: 10.1046/j.1365-2222.2000.00928.x – ident: e_1_2_12_26_1 doi: 10.1016/j.alit.2017.02.001 – ident: e_1_2_12_27_1 – ident: e_1_2_12_13_1 doi: 10.1111/j.1399-3038.2010.00990.x – ident: e_1_2_12_22_1 doi: 10.1111/all.12614 – ident: e_1_2_12_21_1 doi: 10.1016/j.jaci.2005.12.1303 – ident: e_1_2_12_28_1 doi: 10.1111/all.13198 – ident: e_1_2_12_8_1 doi: 10.1016/j.jaci.2013.06.042 – year: 2020 ident: e_1_2_12_12_1 article-title: Food Anaphylaxis in the United Kingdom: an analysis of national data. 1998–2018 publication-title: BMJ – ident: e_1_2_12_10_1 doi: 10.1111/pai.12148 – ident: e_1_2_12_11_1 doi: 10.1111/all.12613 – ident: e_1_2_12_18_1 doi: 10.1016/j.jaip.2020.06.059 – ident: e_1_2_12_16_1 doi: 10.1186/s12889-018-6117-y – ident: e_1_2_12_9_1 doi: 10.1016/j.jaci.2014.03.035 – ident: e_1_2_12_7_1 doi: 10.1016/j.jaci.2012.10.017 – ident: e_1_2_12_17_1 doi: 10.3389/fimmu.2018.02057 – ident: e_1_2_12_2_1 doi: 10.1016/j.fct.2013.10.032 – volume: 14 start-page: 29 issue: 1 year: 2012 ident: e_1_2_12_15_1 article-title: Lessons from 482 cases of mortality due to food allergy in Israel: cow's milk protein should be considered a potentially fatal allergen publication-title: Isr Med Assoc J – ident: e_1_2_12_23_1 doi: 10.1016/j.fct.2020.111831 – ident: e_1_2_12_20_1 doi: 10.1111/j.1398-9995.2011.02715.x – ident: e_1_2_12_3_1 doi: 10.1016/j.fct.2020.111259 – ident: e_1_2_12_31_1 doi: 10.1067/mai.2001.114708 – ident: e_1_2_12_6_1 doi: 10.1016/j.jaci.2019.07.046 – ident: e_1_2_12_14_1 doi: 10.1016/j.jaip.2019.04.025 – ident: e_1_2_12_29_1 doi: 10.1186/s40413-016-0104-5 – ident: e_1_2_12_24_1 doi: 10.1136/bmj.d6180 – ident: e_1_2_12_5_1 doi: 10.1111/pai.13244 – ident: e_1_2_12_25_1 doi: 10.1111/all.12625 |
SSID | ssj0017361 |
Score | 2.4388454 |
Snippet | Background
There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution... There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold... BackgroundThere is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1056 |
SubjectTerms | Allergens Allergies Anaphylaxis Animals Cattle Cheese Child Children Cow's milk eliciting dose Epinephrine Female Food allergies Humans Male Milk Milk Hypersensitivity - diagnosis Proteins single‐dose challenge thresholds Voluntary Incidental Trace Allergen Labelling (VITAL) |
Title | Single‐dose oral challenges to validate eliciting doses in children with cow’s milk allergy |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpai.13482 https://www.ncbi.nlm.nih.gov/pubmed/33608940 https://www.proquest.com/docview/2546803755 https://www.proquest.com/docview/2491945994 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwEB6VHhAXoKwP2sogDlzy5MR2YotT1VIVpKIKqNQDUuQtKOojqZr3hODUn8CVv9dfgsdZRFkkxC1SJvE2Y8-MZ74BeOYFZV5yk2jEGeKSukSnqU2EdimVlTI85lYdvskPjvnrE3GyBi_GXJgeH2JyuKFkxP0aBVyb7ichP9P1PEVolrD_pixH3Py9txN0VFqwiJVKFRXBPBLFgCqEUTzTl1fPot8UzKv6ajxw9m_Bh7GrfZzJ6Xy1NHP79RcUx_8cy224OSiiZKfnnA1Y880duH44XLXfhfJdONQW_vLim2s7TzCRn9ix8kpHli0JPFqjv4CExm2N4dMESTtSN2TMESfo5yW2_Xx58b0jn-rFKcFfnH_8cg-O91--3z1IhmoMiWWohgsrM55L4zUmfjBEsqM6k0JUyjFj0DKSlcgqrF1vjFLOSF9UruDO81RZyu7DetM2_iEQvHo1ufYmD8alzAtji4K6wtlcp0ZZNoPn47qUdoAqx4oZi3I0WcKElXHCZvB0Ij3r8Tn-RLQ5Lm45iGhXYiEAiRWAxQyeTK-DcOGNiW58uwo0XKWKC6X4DB70TDG1wlhOpeI0dDYu7d-bL492XsWHR_9O-hhuZBg9EwODN2F9eb7yW0H9WZptuJbxo-3I7T8A-08Bnw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkEvvGkXChjEgUtWztpObKmXClFtoVshaKVeUBQ_gqJuk6rZFYJTfwLX_r3-EjzOQ5SHhLhFyiR27Jl4nt8AvHSCMie5jnLEGeKS2iiPYxOJ3MZUFkrzUFs120-mh_ztkThaga2-FqbFhxgcbigZ4X-NAo4O6Z-k_DQvxzFis1yD6yE-hyrRhwE8Kk5ZQEuligpvIIm0wxXCPJ7h0aun0W8q5lWNNRw5O7fhUz_ZNtPkeLxc6LH59guO4_9-zR241emiZLtlnruw4qp7cGPWRdvvQ_bRn2tzd3n-3daNI1jLT0zffKUhi5p4Ni3RZUD86KbEDGqCpA0pK9KXiRN09RJTf7k8v2jISTk_JviKs89fH8DhzpuD19Ooa8gQGYaauDBywhOpXY61HwzB7Gg-kUIUyjKt0TiShZgU2L5ea6Wsli4tbMqt47EylD2E1aqu3AYQjL7qJHc68falTFJt0pTa1Jokj7UybASv-o3JTIdWjk0z5llvtfgFy8KCjeDFQHraQnT8iWiz392sk9Imw14AEpsAixE8H257-cKgSV65eulpuIoVF0rxEay3XDGMwlhCpeLUTzbs7d-Hz95v74aLR_9O-gxuTg9me9ne7v67x7A2wWSakCe8CauLs6V74rWhhX4amP4H_SQE5g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwEB61Rap6QS0_ZWkBgzhwCXJiO7HFqaKsWqDVSlCpt8h_QRFLsmq2Qtz6CFx5vT4JHm8SUUElbpEyiePxTDzjmfkG4KUXlHnJTaIRZ4hL6hKdpjYR2qVUVsrwWFt1cpofnfH35-J8Dd4MtTArfIjxwA01I_6vUcEXrvpDyRe6fp0iNMs63OFB7lC8Mz4bQwgFi2CpVFER_CNR9LBCmMYzPnpzM_rLwrxpsMYdZ7oNd3tTkRys1nYH1nxzDzZP-mD4fSg_hW1n7q-vfrq28wRL7YkdeqN0ZNmSIEU1evQkTNXWmOBMkLQjdUOGKm6CJ7HEtt-vr3515Fs9_0rwFRdffjyAs-m7z2-Pkr5fQmIZGsrCyozn0niNpRkMseaozqQQlXLMGPRdZCWyCrvLG6OUM9IXlSu48zxVlrKHsNG0jX8EBIOjJtfe5MH9k3lhbFFQVzib69QoyybwamBcaXswcexpMS8HpyLwuIw8nsCLkXSxQtD4F9H-wP2yV6KuRKh-iT16xQSej7eD-GNMQze-vQw0XKWKC6X4BHZXqzaOwlhOpeI0fGxcxtuHL2cHx_Hi8f-TPoPN2eG0_Hh8-mEPtjJMdYlZvPuwsby49E-CrbI0T6NM_gZujuNY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single%E2%80%90dose+oral+challenges+to+validate+eliciting+doses+in+children+with+cow%E2%80%99s+milk+allergy&rft.jtitle=Pediatric+allergy+and+immunology&rft.au=Turner%2C+Paul+J.&rft.au=d%27Art%2C+Yvonne+M.&rft.au=Duca%2C+Bettina&rft.au=Chastell%2C+Sophia+A.&rft.date=2021-07-01&rft.issn=0905-6157&rft.eissn=1399-3038&rft.volume=32&rft.issue=5&rft.spage=1056&rft.epage=1065&rft_id=info:doi/10.1111%2Fpai.13482&rft.externalDBID=10.1111%252Fpai.13482&rft.externalDocID=PAI13482 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-6157&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-6157&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-6157&client=summon |